C. Haslett

发表

Regulation of Pulmonary and Systemic Bacterial Lipopolysaccharide Responses in Transgenic Mice Expressing Human Elafin

C. Haslett, J. Sallenave, G. Mclachlan, 2003, Infection and Immunity.

Downregulation of Mcl-1 has anti-inflammatory pro-resolution effects and enhances bacterial clearance from the lung

J. Marwick, C. Haslett, R. Duffin, 2013, Mucosal Immunology.

Galectin-3 reduces the severity of pneumococcal pneumonia by augmenting neutrophil function.

K. Dhaliwal, C. Haslett, A. MacKinnon, 2008, The American journal of pathology.

Molecular characterization of the surface of apoptotic neutrophils: Implications for functional downregulation and recognition by phagocytes

C. Haslett, J. Ross, S. Hart, 2000, Cell Death and Differentiation.

Regulation of cell adhesion molecule expression and function associated with neutrophil apoptosis.

C. Haslett, I. Dransfield, S. Stocks, 1995, Blood.

Neutrophil-mediated injury to endothelial cells. Enhancement by endotoxin and essential role of neutrophil elastase.

C. Haslett, P. Henson, R. Johnston, 1986, The Journal of clinical investigation.

Elafin (elastase‐specific inhibitor) has anti‐microbial activity against Gram‐positive and Gram‐negative respiratory pathogens

C. Haslett, J. Sallenave, A. J. Simpson, 1999, FEBS letters.

Diagnostic importance of pulmonary interleukin-1 beta and interleukin-8 in ventilator-associated pneumonia

T. S. Wilkinson, C. Haslett, J. Sallenave, 2009 .

Combined dysfunctions of immune cells predict nosocomial infection in critically ill patients.

T. S. Wilkinson, T. Walsh, K. Dhaliwal, 2013, British journal of anaesthesia.

Pharmacological manipulation of granulocyte apoptosis: potential therapeutic targets.

C. Haslett, C. Ward, E. Chilvers, 1999, Trends in pharmacological sciences.

Soluble E-selectin acts in synergy with platelet-activating factor to activate neutrophil beta 2-integrins. Role of tyrosine kinases and Ca2+ mobilization.

C. Haslett, I. Dransfield, M. Ruchaud-Sparagano, 2000, The Journal of biological chemistry.

Nitric oxide: a key regulator of myeloid inflammatory cell apoptosis

C. Haslett, I. Megson, A. Rossi, 2003, Cell Death and Differentiation.

Dissociation of DNA fragmentation from other hallmarks of apoptosis in nitric oxide-treated neutrophils: differences between individual nitric oxide donor drugs.

C. Haslett, I. Megson, E. Taylor, 2001, Biochemical and biophysical research communications.

Transient elevations of cytosolic free calcium retard subsequent apoptosis in neutrophils in vitro.

C. Haslett, J. Savill, M. Whyte, 1993, The Journal of clinical investigation.

The presence of a constitutively active phosphoinositide 3-kinase in small cell lung cancer cells mediates anchorage-independent proliferation via a protein kinase B and p70s6k-dependent pathway.

R. Rintoul, C. Haslett, E. Chilvers, 1998, Cancer research.

Cellular mechanisms of acute lung injury: implications for future treatment in the adult respiratory distress syndrome.

C. Haslett, S. Donnelly, Christopher Haslett, 1992, Thorax.

Induction of human neutrophil apoptosis by nitric oxide donors: evidence for a caspase-dependent, cyclic-GMP-independent, mechanism.

I. Rahman, C. Haslett, C. Ward, 2000, Biochemical pharmacology.

ECM overrides DNA damage-induced cell cycle arrest and apoptosis in small-cell lung cancer cells through β1 integrin-dependent activation of PI3-kinase

R. Rintoul, C. Haslett, T. Sethi, 2006, Cell Death and Differentiation.